← Eichor
Study identifier: NCT04558541 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Developmental Framework For Linking Phonological And Morpho-syntactic Sequential Pattern Rules In DLD: Production

Condition: Developmental Language Disorder · Speech Sound Disorder · Specific Language Impairment  ·  Sponsor: Father Flanagan's Boys' Home

PhaseNA
Planned participants400
Who can joinAll sexes, 4 Years to 8 Years
Healthy volunteersYes

About this study

The broad aim of this clinical study is to assess the hypothesis that morphological and phonological deficits are linked by a broader deficit in sequential pattern learning. This hypothesis applies to learning in general, but is especially critical as an avenue for developing earlier assessments and more powerful interventions for children with developmental language disorder (DLD; also known as specific language impairment). Other populations, such as at-risk toddlers, may also benefit from this new approach.

This description comes directly from the study's public registry record.

Talk to the study team

Lisa Goffman, PhD  ·  531-355-5038  ·  lisa.goffman@boystown.org

LouAnn Gerken, PhD  ·  gerken@email.arizona.edu

Always discuss trial participation with your own doctor first.

Locations (2)

University of ArizonaTucson, Arizona, United StatesRecruiting
Boys Town National Research HospitalOmaha, Nebraska, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04558541